Active Ingredient(s):Epoetin Alfa FDA Approved: * December 3, 1993 Pharm Company: *AMGEN Category:Anemia
Epoetin alfa is a human erythropoietin produced in cell culture using recombinant DNA technology. Authorised by the European Medicines Agency on 28 August 2007, it stimulates erythropoiesis (increasing red blood cell levels) and is used to treat anemia, commonly associated with chronic kidney failure and cancer chemotherapy.
Epoetin is manufactured and marketed by Amgen under the trade name Epogen. Johnson & Johnson subsidiary Janssen Biotech (formerly Ortho Biotech Pro...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion